Loading company…
Culver City company providing decentralized clinical trial infrastructure that connects patients, providers and researchers.
Science 37 provides a configurable decentralized clinical trial operating system, offering mobile nurses, remote coordinators, patient communities and connected devices for research across many therapeutic areas. Founded in 2014 by Noah Craft and Belinda Tan and based in Culver City, California, it is led by CEO David Coman. It raised USD 40.0 million in venture funding in 2020, co-led by Lux Capital Management, Redmile Group and PPD Investments. In 2021 LifeSci Acquisition II Corp, a SPAC, combined with the company at a valuation of USD 1.05 billion, with a USD 200 million PIPE.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in